Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fenwal
Lake Zurich, Illinois, United Statesfenwalinc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Fenwal was a global leader in transfusion medicine technologies with commercialized products for automated and manual blood collection, separation, filtration, storage, and transfusion. Its innovations enabled safer and more efficient blood supply management worldwide. The company was acquired by Fresenius Kabi in 2012 to form a global leader in transfusion technology.[8][5][6]
- Therapeutic areas
- HematologyNeurologyOncologyOther
- Modalities
- DeviceBiologicCell therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
Collaborations with hospitals/blood banks globallypartnerships with biotech/pharma companies for enabling cell therapy research/manufacturing
Beyond the preview
Go deeper on Fenwal.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fenwal.